Table 3.
Potential predictors influencing disease progression
| Without disease progression (n = 8) | With disease progression (n = 12) | p value | |
|---|---|---|---|
| Histological subtype | |||
| Squamous | 7 | 8 | 0.307 |
| Non-squamous | 1 | 4 | |
| M stage | |||
| M0 | 7 | 6 | 0.106 |
| MA | 1 | 6 | |
| Initial tumor size (cm) | 7.7 (4-14) | 7.9 (6.4-11.4) | 0.821 |
| Hydronephrosis | |||
| Yes | 1 | 3 | 0.465 |
| No | 7 | 9 | |
| Corpus invasion | |||
| Yes | 5 | 9 | 0.455 |
| No | 3 | 3 | |
| Pyometra | |||
| Yes | 2 | 3 | 0.693 |
| No | 6 | 9 | |
| Hemoglobin value at initial presentation (g/dl) | 12.4 (11.6-13.1) | 11.5 (8.3-12.8) | 0.085 |
| Concurrent chemotherapy | |||
| Yes | 8 | 9 | 0.193 |
| No | 0 | 3 | |
| HR-CTV D90 in EQD2 (Gy) | 74.3 (67.3-80.8) | 72.9 (60.4-88.5) | 0.687 |
| HR-CTV (ml) | 119.2 (6.6-175.6) | 115.5 (28.2-167.9) | 0.336 |